Showing results (151-160 of 592) with videos related to
Sort By:
Pageof 60
Tuberculosis and Respiratory Diseases|January 14, 2014
Adjuvant treatment of proper endobronchial management in leiomyosarcomaSoo Jung Kim, Junghyun Kim, Ju-Hee Park, et al.Journal of Cancer Research and Clinical Oncology|July 10, 2014
The gefitinib dose reduction on survival outcomes in epidermal growth factor receptor mutant non-small cell lung cancerSung Hoon Sim, Bhumsuk Keam, Dong-Wan Kim, et al.Cancer Research and Treatment|December 30, 2014
The Impact of Molecularly Targeted Treatment on Direct Medical Costs in Patients with Advanced Non-small Cell Lung CancerJune-Koo Lee, Dong-Wan Kim, Bhumsuk Keam, et al.Neoplasia (New York, N.Y.)|August 7, 2026
EZH1/2 inhibition selectively targets SMARCA4/2 co-deficient lung cancer cells by suppressing stemness and proliferationJeongjae Lee, Jaeik Oh, Soyeon Kim, et al.Journal of Orthopaedic Science : Official Journal of the Japanese Orthopaedic Association|June 22, 2021
Intraoperative evaluation of DRUJ instability through dorsal stress radiography in distal radius fracturesSamuel Baek, Se Bong Oh, Jung Ho Lee, et al.Molecular Cancer Therapeutics|February 18, 2016
Targeting Adenine Nucleotide Translocase-2 (ANT2) to Overcome Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Non-Small Cell Lung CancerJi-Young Jang, Yong-Goo Kim, Soo Jeong Nam, et al.Cancer Science|November 24, 2011
Influence of chemotherapy on nitric oxide synthase, indole-amine-2,3-dioxygenase and CD124 expression in granulocytes and monocytes of non-small cell lung cancerSung Hoon Sim, Yong-Oon Ahn, Jieun Yoon, et al.Cancer Research and Treatment|October 13, 2018
Acquired Resistance of MET-Amplified Non-small Cell Lung Cancer Cells to the MET Inhibitor CapmatinibSeulki Kim, Tae Min Kim, Dong-Wan Kim, et al.Diagnostic Pathology|June 22, 2024
Transformation of t(14;18)-negative follicular lymphoma to plasmablastic lymphoma: a case report with analysis of genetic evolutionSojung Lim, Jiwon Koh, Jeong Mo Bae, et al.Chemical Communications (Cambridge, England)|September 2, 2020
Cancer cell death using metabolic glycan labelling techniquesSang-Hyun Park, Hyoje Jung, Hosoowi Lee, et al.Pageof 60